PNC Financial Services Group’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-40
| Closed | -$490 | – | 5205 |
|
|
2025
Q3 | $490 | Hold |
40
| – | – | ﹤0.01% | 4804 |
|
|
2025
Q2 | $212 | Buy |
+40
| New | +$292 | ﹤0.01% | 4794 |
|
|
2025
Q1 | – | Sell |
-24
| Closed | -$319 | – | 4938 |
|
|
2024
Q4 | $319 | Hold |
24
| – | – | ﹤0.01% | 4595 |
|
|
2024
Q3 | $241 | Hold |
24
| – | – | ﹤0.01% | 4661 |
|
|
2024
Q2 | $538 | Hold |
24
| – | – | ﹤0.01% | 4518 |
|
|
2024
Q1 | $1.42K | Hold |
24
| – | – | ﹤0.01% | 4282 |
|
|
2023
Q4 | $534 | Sell |
24
-22
| -48% | -$332 | ﹤0.01% | 4405 |
|
|
2023
Q3 | $983 | Buy |
+46
| New | +$1.81K | ﹤0.01% | 4373 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4489 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | -$1.28K | – | 4562 |
|
|
2022
Q1 | $2K | Buy |
+5
| New | +$1.74K | ﹤0.01% | 4185 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4491 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$354 | – | 4329 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 4106 |
|
|
2021
Q1 | $1K | Sell |
1
-281
| -100% | -$299K | ﹤0.01% | 4021 |
|
|
2020
Q4 | $263K | Buy |
282
+157
| +126% | +$165K | ﹤0.01% | 1892 |
|
|
2020
Q3 | $129K | Buy |
125
+124
| +12,400% | +$133K | ﹤0.01% | 2172 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 3844 |
|
|
2020
Q1 | $1K | Buy |
+1
| New | +$994 | ﹤0.01% | 3803 |
|
|
2019
Q4 | – | Sell |
-170
| Closed | -$174K | – | 3877 |
|
|
2019
Q3 | $157K | Buy |
170
+6
| +4% | +$6.59K | ﹤0.01% | 2281 |
|
|
2019
Q2 | $185K | Buy |
164
+162
| +8,100% | +$177K | ﹤0.01% | 2209 |
|
|
2019
Q1 | $2K | Buy |
2
+1
| +100% | +$1.36K | ﹤0.01% | 3866 |
|
|
2018
Q4 | $1K | Sell |
1
-99
| -99% | -$111K | ﹤0.01% | 3947 |
|
|
2018
Q3 | $153K | Sell |
100
-7
| -7% | -$10.8K | ﹤0.01% | 2336 |
|
|
2018
Q2 | $168K | Sell |
107
-1,050
| -91% | -$1.37M | ﹤0.01% | 2295 |
|
|
2018
Q1 | $1.34M | Buy |
1,157
+1,156
| +115,600% | +$1.52M | ﹤0.01% | 1191 |
|
|
2017
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 3946 |
|
|
2017
Q3 | $1K | Buy |
+1
| New | +$1.05K | ﹤0.01% | 4073 |
|
|
2016
Q3 | – | Sell |
-11
| Closed | -$5K | – | 4081 |
|
|
2016
Q2 | $5K | Sell |
11
-1,649
| -99% | -$755K | ﹤0.01% | 3832 |
|
|
2016
Q1 | $883K | Buy |
1,660
+230
| +16% | +$115K | ﹤0.01% | 1302 |
|
|
2015
Q4 | $1.09M | Buy |
1,430
+1,414
| +8,838% | +$938K | ﹤0.01% | 1173 |
|
|
2015
Q3 | $9K | Hold |
16
| – | – | ﹤0.01% | 3709 |
|
|
2015
Q2 | $9K | Buy |
16
+15
| +1,500% | +$8.72K | ﹤0.01% | 3838 |
|
|
2015
Q1 | $1K | Buy |
+1
| New | +$775 | ﹤0.01% | 4472 |
|
Other funds holding KYNB
AC
DS
PNC Financial Services Group's KYNB Position: Q4 2025 in Review
PNC Financial Services Group sold out of Kyntra Bio (KYNB) in Q4 2025, closing a stake of 40 shares — an estimated $490 sold.
PNC Financial Services Group first reported a position in KYNB in Q1 2015 and held it in 30 quarters. The position peaked at $1.34M in Q1 2018. 34 funds tracked by Wall St. Rank hold KYNB as of Q4 2025.
- PNC Financial Services Group reported no remaining Kyntra Bio position as of Q4 2025 after selling out during the quarter.
- PNC Financial Services Group sold 40 Kyntra Bio shares in Q4 2025, an estimated $490.
- PNC Financial Services Group first reported a position in Kyntra Bio in Q1 2015 and held it in 30 quarters.
- PNC Financial Services Group's Kyntra Bio position peaked at $1.34M in Q1 2018.
- 34 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2025.
Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.